{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:19:27Z","timestamp":1762867167454},"reference-count":182,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["seminoncol.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1053\/j.seminoncol.2017.06.005","type":"journal-article","created":{"date-parts":[[2017,7,11]],"date-time":"2017-07-11T09:19:16Z","timestamp":1499764756000},"page":"101-112","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Eviction from the sanctuary: Development of targeted therapy against cell adhesion molecules in acute lymphoblastic leukemia"],"prefix":"10.1053","volume":"44","author":[{"given":"Sonali P.","family":"Barwe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Quagliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anilkumar","family":"Gopalakrishnapillai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2017.06.005_bib1","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0140-6736(12)62187-4","article-title":"Acute lymphoblastic leukaemia","volume":"381","author":"Inaba","year":"2013","journal-title":"Lancet"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib2","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1200\/JCO.2010.30.1382","article-title":"Modern therapy of acute lymphoblastic leukemia","volume":"29","author":"Bassan","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib3","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1200\/JCO.2011.37.8018","article-title":"Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group","volume":"30","author":"Hunger","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/asheducation-2010.1.7","article-title":"Minimal residual disease in acute lymphoblastic leukemia","author":"Campana","year":"2010","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib5","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1182\/blood-2009-11-253435","article-title":"Clinical significance of low levels of minimal residual disease at the end of remission induction therapy in childhood acute lymphoblastic leukemia","volume":"115","author":"Stow","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib6","first-page":"5667","article-title":"Drug-resistance profile in multiple-relapsed childhood acute lymphoblastic leukemia","volume":"35","author":"Pogorzala","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib7","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1126\/science.1164390","article-title":"Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells","volume":"322","author":"Colmone","year":"2008","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib8","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0145-2126(01)00051-0","article-title":"Bone marrow stromal cells regulate caspase 3 activity in leukemic cells during chemotherapy","volume":"25","author":"Fortney","year":"2001","journal-title":"Leuk Res"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib9","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1182\/blood.V79.9.2370.2370","article-title":"Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia","volume":"79","author":"Manabe","year":"1992","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1006\/excr.1996.0201","article-title":"Molecular interactions between human B-cell progenitors and the bone marrow microenvironment","volume":"226","author":"Murti","year":"1996","journal-title":"Exp Cell Res"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib11","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1182\/blood-2010-01-262691","article-title":"Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers","volume":"117","author":"Pillozzi","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib12","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.exphem.2015.09.003","article-title":"Bone marrow microenvironment modulation of acute lymphoblastic leukemia phenotype","volume":"44","author":"Moses","year":"2016","journal-title":"Exp Hematol"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib13","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1182\/blood.V96.5.1926","article-title":"Stromal cells regulate survival of B-lineage leukemic cells during chemotherapy","volume":"96","author":"Mudry","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib14","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1182\/blood.V82.11.3437.3437","article-title":"Analysis of the mechanism of adhesion of precursor-B acute lymphoblastic leukemia cells to bone marrow fibroblasts","volume":"82","author":"Bradstock","year":"1993","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000305344","article-title":"Adhesion-induced drug resistance in leukemia stem cells","volume":"86","author":"Funayama","year":"2010","journal-title":"Pharmacology"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib16","first-page":"86","article-title":"Adhesion of precursor-B acute lymphoblastic leukaemia cells to bone marrow stromal proteins","volume":"7","author":"Makrynikola","year":"1993","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3109\/09687689709044318","article-title":"Cell adhesion: more than just glue (review)","volume":"15","author":"Buckley","year":"1998","journal-title":"Mol Membr Biol"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib18","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0092-8674(02)00971-6","article-title":"Integrins: bidirectional, allosteric signaling machines","volume":"110","author":"Hynes","year":"2002","journal-title":"Cell"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib19","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.3324\/haematol.2011.047993","article-title":"High VLA-4 expression is associated with adverse outcome and distinct gene expression changes in childhood B-cell precursor acute lymphoblastic leukemia at first relapse","volume":"96","author":"Shalapour","year":"2011","journal-title":"Haematologica"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib20","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1182\/blood-2012-01-406272","article-title":"Integrin alpha4 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy","volume":"121","author":"Hsieh","year":"2013","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib21","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1038\/leu.2014.182","article-title":"Effects of the small-molecule inhibitor of integrin alpha4, TBC3486, on pre-B-ALL cells","volume":"28","author":"Hsieh","year":"2014","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib22","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1158\/0008-5472.CAN-13-2159","article-title":"Redox modulation of adjacent thiols in VLA-4 by AS101 converts myeloid leukemia cells from a drug-resistant to drug-sensitive state","volume":"74","author":"Layani-Bazar","year":"2014","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib23","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1182\/blood-2012-12-475483","article-title":"Adhesion to osteopontin in the bone marrow niche regulates lymphoblastic leukemia cell dormancy","volume":"121","author":"Boyerinas","year":"2013","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib24","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.2174\/138161210791920450","article-title":"LFA-1 on leukemic cells as a target for therapy or drug delivery","volume":"16","author":"Phongpradist","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib25","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1182\/blood-2003-12-4218","article-title":"The HMG-CoA reductase inhibitor simvastatin overcomes cell adhesion-mediated drug resistance in multiple myeloma by geranylgeranylation of Rho protein and activation of Rho kinase","volume":"104","author":"Schmidmaier","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib26","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1242\/jcs.114.4.629","article-title":"The cadherin superfamily: diversity in form and function","volume":"114","author":"Angst","year":"2001","journal-title":"J Cell Sci"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib27","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1471-4914(03)00071-6","article-title":"The role of selectins in inflammation and disease","volume":"9","author":"Ley","year":"2003","journal-title":"Trends Mol Med"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib28","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/sj.leu.2404688","article-title":"Microarray-based classification of a consecutive series of 121 childhood acute leukemias: prediction of leukemic and genetic subtype as well as of minimal residual disease status","volume":"21","author":"Andersson","year":"2007","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib29","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1182\/blood-2010-12-324004","article-title":"New markers for minimal residual disease detection in acute lymphoblastic leukemia","volume":"117","author":"Coustan-Smith","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib30","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1200\/JCO.2009.23.4732","article-title":"Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group","volume":"28","author":"Haferlach","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib31","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1182\/blood-2011-07-368050","article-title":"P-selectin glycoprotein ligand regulates the interaction of multiple myeloma cells with the bone marrow microenvironment","volume":"119","author":"Azab","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib32","series-title":"First in human phase 1 single dose escalation studies of the E-selectin antagonist GMI-1271 show a favorable safety, pharmacokinetic, and biomarker profile","author":"Devata","year":"2015"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib33","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1044-5323(03)00047-2","article-title":"Membrane proteins with immunoglobulin-like domains--a master superfamily of interaction molecules","volume":"15","author":"Barclay","year":"2003","journal-title":"Semin Immunol"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib34","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cell.2009.05.045","article-title":"CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells","volume":"138","author":"Majeti","year":"2009","journal-title":"Cell"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib35","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1158\/0008-5472.CAN-10-2238","article-title":"Therapeutic antibody targeting of CD47 eliminates human acute lymphoblastic leukemia","volume":"71","author":"Chao","year":"2011","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib36","first-page":"1189","article-title":"Antitumor activity of a monoclonal antibody against CD47 in xenograft models of human leukemia","volume":"17","author":"Uno","year":"2007","journal-title":"Oncol Rep"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib37","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s12094-016-1489-x","article-title":"CD47: a potential immunotherapy target for eliminating cancer cells","volume":"18","author":"Kong","year":"2016","journal-title":"Clin Transl Oncol"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib38","doi-asserted-by":"crossref","first-page":"e0137345","DOI":"10.1371\/journal.pone.0137345","article-title":"Pre-clinical development of a humanized anti-CD47 antibody with anti-cancer therapeutic potential","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS One"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib39","doi-asserted-by":"crossref","first-page":"6206","DOI":"10.1182\/blood-2008-06-162123","article-title":"Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100","volume":"113","author":"Nervi","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib40","doi-asserted-by":"crossref","first-page":"8947","DOI":"10.18632\/oncotarget.2407","article-title":"Plerixafor as a chemosensitizing agent in pediatric acute lymphoblastic leukemia: efficacy and potential mechanisms of resistance to CXCR4 inhibition","volume":"5","author":"Sison","year":"2014","journal-title":"Oncotarget"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib41","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.exphem.2012.11.004","article-title":"Plerixafor (AMD3100) induces prolonged mobilization of acute lymphoblastic leukemia cells and increases the proportion of cycling cells in the blood in mice","volume":"41","author":"Welschinger","year":"2013","journal-title":"Exp Hematol"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib42","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/leu.2011.76","article-title":"Combination of drug therapy in acute lymphoblastic leukemia with a CXCR4 antagonist","volume":"25","author":"Parameswaran","year":"2011","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib43","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1182\/blood-2011-10-383406","article-title":"A phase 1\/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia","volume":"119","author":"Uy","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib44","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.bbmt.2014.04.020","article-title":"Phase I study of the safety and pharmacokinetics of plerixafor in children undergoing a second allogeneic hematopoietic stem cell transplantation for relapsed or refractory leukemia","volume":"20","author":"Srinivasan","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib45","doi-asserted-by":"crossref","first-page":"30902","DOI":"10.18632\/oncotarget.5094","article-title":"POL5551, a novel and potent CXCR4 antagonist, enhances sensitivity to chemotherapy in pediatric ALL","volume":"6","author":"Sison","year":"2015","journal-title":"Oncotarget"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib46","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1158\/1078-0432.CCR-12-2333","article-title":"BMS-936564\/MDX-1338: a fully human anti-CXCR4 antibody induces apoptosis in vitro and shows antitumor activity in vivo in hematologic malignancies","volume":"19","author":"Kuhne","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib47","series-title":"The dual E-selectin\/CXCR4 inhibitor, GMI-1359, enhances efficacy of anti-leukemia chemotherapy in FLT3-ITD mutated acute myeloid leukemia","author":"Zhang","year":"2015"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib48","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ccr.2013.02.026","article-title":"A human ICAM-1 antibody isolated by a function-first approach has potent macrophage-dependent antimyeloma activity in vivo","volume":"23","author":"Veitonmaki","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib49","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1158\/1078-0432.CCR-14-3090","article-title":"A phase I dose-escalation study of antibody BI-505 in relapsed\/refractory multiple myeloma","volume":"21","author":"Hansson","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib50","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0162-3109(95)00050-X","article-title":"Thalidomide selectively modulates the density of cell surface molecules involved in the adhesion cascade","volume":"31","author":"Geitz","year":"1996","journal-title":"Immunopharmacology"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib51","first-page":"1105","article-title":"Down-regulation of cell adhesion molecules LFA-1 and ICAM-1 after in vitro treatment with the anti-TNF-alpha agent thalidomide","volume":"47","author":"Settles","year":"2001","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib52","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1200\/JCO.2010.30.3339","article-title":"Dose escalation of lenalidomide in relapsed or refractory acute leukemias","volume":"28","author":"Blum","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib53","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.1998.tb01567.x","article-title":"Ecto-enzymes of lymphoid cells","volume":"161","author":"Goding","year":"1998","journal-title":"Immunol Rev"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib54","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0301-472X(01)00741-X","article-title":"The chemokine receptor CXCR4 enhances integrin-mediated in vitro adhesion and facilitates engraftment of leukemic precursor-B cells in the bone marrow","volume":"29","author":"Shen","year":"2001","journal-title":"Exp Hematol"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib55","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1038\/onc.2015.449","article-title":"Tetraspanin CD82 regulates bone marrow homing of acute myeloid leukemia by modulating the molecular organization of N-cadherin","volume":"35","author":"Marjon","year":"2016","journal-title":"Oncogene"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib56","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/leu.2013.256","article-title":"SP\/drug efflux functionality of hematopoietic progenitors is controlled by mesenchymal niche through VLA-4\/CD44 axis","volume":"28","author":"Malfuson","year":"2014","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib57","first-page":"87","article-title":"Galectins as therapeutic targets for hematological malignancies: a hopeful sweetness","volume":"2","author":"Pena","year":"2014","journal-title":"Ann Transl Med"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib58","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/MOH.0b013e328362370f","article-title":"Galectins in hematological malignancies","volume":"20","author":"Giordano","year":"2013","journal-title":"Curr Opin Hematol"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib59","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.bbamcr.2015.08.008","article-title":"Galectin 3 as a guardian of the tumor microenvironment","volume":"1863","author":"Ruvolo","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib60","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00277-013-1939-2","article-title":"Targeting connective tissue growth factor (CTGF) in acute lymphoblastic leukemia preclinical models: anti-CTGF monoclonal antibody attenuates leukemia growth","volume":"93","author":"Lu","year":"2014","journal-title":"Ann Hematol"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib61","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.1365-2141.2007.06739.x","article-title":"High expression of connective tissue growth factor in pre-B acute lymphoblastic leukaemia","volume":"138","author":"Boag","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib62","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.leukres.2011.08.001","article-title":"Interactions between acute lymphoblastic leukemia and bone marrow stromal cells influence response to therapy","volume":"36","author":"Tesfai","year":"2012","journal-title":"Leuk Res"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib63","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1038\/onc.2015.525","article-title":"High expression of connective tissue growth factor accelerates dissemination of leukaemia","volume":"35","author":"Wells","year":"2016","journal-title":"Oncogene"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib64","first-page":"5033","article-title":"Resistance to glucocorticoid-induced apoptosis in human T-cell acute lymphoblastic leukemia CEM-C1 cells is due to insufficient glucocorticoid receptor expression","volume":"56","author":"Geley","year":"1996","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib65","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/sj.leu.2402128","article-title":"High level resistance to glucocorticoids, associated with a dysfunctional glucocorticoid receptor, in childhood acute lymphoblastic leukemia cells selected for methotrexate resistance","volume":"15","author":"Catts","year":"2001","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib66","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/1479-7364-3-3-281","article-title":"Human ATP-binding cassette (ABC) transporter family","volume":"3","author":"Vasiliou","year":"2009","journal-title":"Hum Genomics"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib67","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/sj.leu.2404692","article-title":"ABC transporters and drug resistance in leukemia: was P-gp nothing but the first head of the Hydra?","volume":"21","author":"Steinbach","year":"2007","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib68","first-page":"5","article-title":"ATP binding cassette C1 (ABCC1\/MRP1)-mediated drug efflux contributes to disease progression in T-lineage acute lymphoblastic leukemia","author":"Winter","year":"2013","journal-title":"Health (Irvine Calif)"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib69","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.1182\/blood-2002-11-3461","article-title":"The multidrug resistance-associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male patients and T-cell immunophenotype","volume":"102","author":"Steinbach","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib70","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nm.3078","article-title":"Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL","volume":"19","author":"Tzoneva","year":"2013","journal-title":"Nat Med"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2005.01.003","article-title":"The 5'-nucleotidases as regulators of nucleotide and drug metabolism","volume":"107","author":"Hunsucker","year":"2005","journal-title":"Pharmacol Ther"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib72","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.exphem.2014.09.007","article-title":"Variegated clonality and rapid emergence of new molecular lesions in xenografts of acute lymphoblastic leukemia are associated with drug resistance","volume":"43","author":"Nowak","year":"2015","journal-title":"Exp Hematol"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib73","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1182\/blood-2006-11-052373","article-title":"Kinase domain mutations of BCR-ABL frequently precede imatinib-based therapy and give rise to relapse in patients with de novo Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)","volume":"110","author":"Pfeifer","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib74","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.leukres.2015.06.004","article-title":"Up-regulated A20 promotes proliferation, regulates cell cycle progression and induces chemotherapy resistance of acute lymphoblastic leukemia cells","volume":"39","author":"Chen","year":"2015","journal-title":"Leuk Res"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib75","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/0145-2126(90)90070-P","article-title":"A study of multidrug resistance and cell kinetics in a child with near-haploid acute lymphoblastic leukemia","volume":"14","author":"Redner","year":"1990","journal-title":"Leuk Res"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib76","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1349-7006.2009.01432.x","article-title":"Glutathione S-transferase M1 inhibits dexamethasone-induced apoptosis in association with the suppression of Bim through dual mechanisms in a lymphoblastic leukemia cell line","volume":"101","author":"Hosono","year":"2010","journal-title":"Cancer Sci"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib77","doi-asserted-by":"crossref","first-page":"43048","DOI":"10.18632\/oncotarget.5528","article-title":"Stromal cell-mediated mitochondrial redox adaptation regulates drug resistance in childhood acute lymphoblastic leukemia","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib78","doi-asserted-by":"crossref","first-page":"e1470","DOI":"10.1038\/cddis.2014.431","article-title":"Glucose transporter 1-mediated glucose uptake is limiting for B-cell acute lymphoblastic leukemia anabolic metabolism and resistance to apoptosis","volume":"5","author":"Liu","year":"2014","journal-title":"Cell Death Dis"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib79","doi-asserted-by":"crossref","first-page":"E2219","DOI":"10.1073\/pnas.1400958111","article-title":"Mechanistic rationale for targeting the unfolded protein response in pre-B acute lymphoblastic leukemia","volume":"111","author":"Kharabi","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib80","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1182\/blood-2013-01-477620","article-title":"Targeting components of the alternative NHEJ pathway sensitizes KRAS mutant leukemic cells to chemotherapy","volume":"123","author":"Hahnel","year":"2014","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib81","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1182\/blood-2007-09-111773","article-title":"Kpm\/Lats2 is linked to chemosensitivity of leukemic cells through the stabilization of p73","volume":"112","author":"Kawahara","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib82","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.leukres.2013.06.027","article-title":"MiR-125b, miR-100 and miR-99a co-regulate vincristine resistance in childhood acute lymphoblastic leukemia","volume":"37","author":"Akbari","year":"2013","journal-title":"Leuk Res"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib83","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1023\/A:1013156407224","article-title":"Mechanisms associated with cell adhesion mediated drug resistance (CAM-DR) in hematopoietic malignancies","volume":"20","author":"Hazlehurst","year":"2001","journal-title":"Cancer Metastasis Rev"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib84","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.blre.2005.08.003","article-title":"Tumor microenvironment and drug resistance in hematologic malignancies","volume":"20","author":"Li","year":"2006","journal-title":"Blood Rev"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib85","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s10555-014-9545-x","article-title":"Contribution of very late antigen-4 (VLA-4) integrin to cancer progression and metastasis","volume":"34","author":"Schlesinger","year":"2015","journal-title":"Cancer Metastasis Rev"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib86","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1172\/JCI3687","article-title":"VLA-5 is expressed by mouse and human long-term repopulating hematopoietic cells and mediates adhesion to extracellular matrix protein fibronectin","volume":"102","author":"van der Loo","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib87","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.2174\/138161206777947731","article-title":"LFA-1 as a key regulator of immune function: approaches toward the development of LFA-1-based therapeutics","volume":"12","author":"Giblin","year":"2006","journal-title":"Curr Pharm Des"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib88","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/ni984","article-title":"Leukocyte functional antigen 1 lowers T cell activation thresholds and signaling through cytohesin-1 and Jun-activating binding protein 1","volume":"4","author":"Perez","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib89","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1046\/j.1365-2141.1998.00899.x","article-title":"VLA-4 is involved in the engraftment of the human pre-B acute lymphoblastic leukaemia cell line NALM-6 in SCID mice","volume":"102","author":"Filshie","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib90","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1182\/blood-2013-06-511527","article-title":"Reciprocal leukemia-stroma VCAM-1\/VLA-4-dependent activation of NF-kappaB mediates chemoresistance","volume":"123","author":"Jacamo","year":"2014","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib91","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3109\/10428190109097661","article-title":"VLA-4 mediated adhesion to bone marrow stromal cells confers chemoresistance to adherent lymphoma cells","volume":"40","author":"Weekes","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib92","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/onc.2008.385","article-title":"Bortezomib overcomes cell-adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma","volume":"28","author":"Noborio-Hatano","year":"2009","journal-title":"Oncogene"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib93","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1172\/JCI118820","article-title":"Bcr\/Abl expression stimulates integrin function in hematopoietic cell lines","volume":"98","author":"Bazzoni","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib94","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3389\/fonc.2014.00112","article-title":"Integrin VLA-5 and FAK are good targets to improve treatment response in the Philadelphia chromosome positive acute lymphoblastic leukemia","volume":"4","author":"Hu","year":"2014","journal-title":"Front Oncol"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib95","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1046\/j.1365-2141.2001.03182.x","article-title":"Enhanced T-lineage acute lymphoblastic leukaemia cell survival on bone marrow stroma requires involvement of LFA-1 and ICAM-1","volume":"115","author":"Winter","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib96","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1179\/102453308X348315","article-title":"Fibronectin promotes cell proliferation of human pre-B cell line via its interactions with VLA-4 and VLA-5","volume":"13","author":"Harima","year":"2008","journal-title":"Hematology"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib97","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1128\/MCB.00580-13","article-title":"The membrane-proximal KXGFFKR motif of alpha-integrin mediates chemoresistance","volume":"33","author":"Liu","year":"2013","journal-title":"Mol Cell Biol"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib98","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1182\/blood.V93.5.1658","article-title":"Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines","volume":"93","author":"Damiano","year":"1999","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib99","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1189\/jlb.71.3.495","article-title":"Engagement of alpha4beta1 integrin by fibronectin induces in vitro resistance of B chronic lymphocytic leukemia cells to fludarabine","volume":"71","author":"de la Fuente","year":"2002","journal-title":"J Leukoc Biol"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib100","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/nm909","article-title":"Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia","volume":"9","author":"Matsunaga","year":"2003","journal-title":"Nat Med"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib101","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/sj.leu.2405017","article-title":"Combination therapy of an anticancer drug with the FNIII14 peptide of fibronectin effectively overcomes cell adhesion-mediated drug resistance of acute myelogenous leukemia","volume":"22","author":"Matsunaga","year":"2008","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib102","doi-asserted-by":"crossref","first-page":"e9807","DOI":"10.1371\/journal.pone.0009807","article-title":"A New alpha5beta1 integrin-dependent survival pathway through GSK3beta activation in leukemic cells","volume":"5","author":"De Toni-Costes","year":"2010","journal-title":"PLoS One"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib103","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/sj.leu.2402179","article-title":"Cell adhesion-mediated drug resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR\/ABL inhibition, cytotoxic drugs, and gamma-irradiation","volume":"15","author":"Damiano","year":"2001","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib104","doi-asserted-by":"crossref","first-page":"7006","DOI":"10.1074\/jbc.M109.027581","article-title":"Apoptotic death of hematopoietic tumor cells through potentiated and sustained adhesion to fibronectin via VLA-4","volume":"285","author":"Saito","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib105","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1182\/blood-2005-07-2817","article-title":"Combination therapy with lenalidomide plus dexamethasone (Rev\/Dex) for newly diagnosed myeloma","volume":"106","author":"Rajkumar","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib106","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/ni.2824","article-title":"Leukocyte extravasation and vascular permeability are each controlled in vivo by different tyrosine residues of VE-cadherin","volume":"15","author":"Wessel","year":"2014","journal-title":"Nat Immunol"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib107","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1182\/blood-2011-09-377853","article-title":"Osteoblastic N-cadherin is not required for microenvironmental support and regulation of hematopoietic stem and progenitor cells","volume":"120","author":"Bromberg","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib108","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1182\/blood-2011-09-377457","article-title":"N-cadherin in osteolineage cells is not required for maintenance of hematopoietic stem cells","volume":"120","author":"Greenbaum","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib109","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1182\/blood-2009-05-224857","article-title":"Knockdown of N-cadherin suppresses the long-term engraftment of hematopoietic stem cells","volume":"116","author":"Hosokawa","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib110","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1242\/jcs.02398","article-title":"New insights into Fat cadherins","volume":"118","author":"Tanoue","year":"2005","journal-title":"J Cell Sci"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib111","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12307-010-0035-6","article-title":"VE-cadherin regulates Philadelphia chromosome positive acute lymphoblastic leukemia sensitivity to apoptosis","volume":"3","author":"O'Leary","year":"2010","journal-title":"Cancer Microenviron"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib112","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.leukres.2014.09.012","article-title":"Stromal cells attenuate the cytotoxicity of imatinib on Philadelphia chromosome-positive leukemia cells by up-regulating the VE-cadherin\/beta-catenin signal","volume":"38","author":"Chen","year":"2014","journal-title":"Leuk Res"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib113","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1182\/blood-2007-01-068122","article-title":"Ph+\/VE-cadherin+ identifies a stem cell like population of acute lymphoblastic leukemia sustained by bone marrow niche cells","volume":"110","author":"Wang","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib114","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/bjh.13011","article-title":"Wnt inhibition leads to improved chemosensitivity in paediatric acute lymphoblastic leukaemia","volume":"167","author":"Dandekar","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.canlet.2012.11.056","article-title":"Wnt pathway contributes to the protection by bone marrow stromal cells of acute lymphoblastic leukemia cells and is a potential therapeutic target","volume":"333","author":"Yang","year":"2013","journal-title":"Cancer Lett"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib116","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/leu.2008.262","article-title":"beta-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia","volume":"23","author":"Hu","year":"2009","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib117","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.exphem.2008.10.007","article-title":"beta-Catenin is involved in N-cadherin-dependent adhesion, but not in canonical Wnt signaling in E2A-PBX1-positive B acute lymphoblastic leukemia cells","volume":"37","author":"Nygren","year":"2009","journal-title":"Exp Hematol"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib118","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/sj.leu.2404667","article-title":"Increased resistance to a farnesyltransferase inhibitor by N-cadherin expression in Bcr\/Abl-P190 lymphoblastic leukemia cells","volume":"21","author":"Zhang","year":"2007","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib119","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.canlet.2010.03.021","article-title":"Enrichment of N-Cadherin and Tie2-bearing CD34+\/CD38-\/CD123+ leukemic stem cells by chemotherapy-resistance","volume":"296","author":"Zhi","year":"2010","journal-title":"Cancer Lett"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib120","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.leukres.2014.03.007","article-title":"N-Cadherin and Tie2 positive CD34(+)CD38(-)CD123(+) leukemic stem cell populations can develop acute myeloid leukemia more effectively in NOD\/SCID mice","volume":"38","author":"Qiu","year":"2014","journal-title":"Leuk Res"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib121","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1182\/blood-2012-02-412890","article-title":"Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt-beta-catenin signaling","volume":"121","author":"Zhang","year":"2013","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib122","first-page":"271","article-title":"N-cadherin impedes proliferation of the multiple myeloma cancer stem cells","volume":"3","author":"Sadler","year":"2013","journal-title":"Am J Blood Res"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib123","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/leu.2011.319","article-title":"The Fat1 cadherin is overexpressed and an independent prognostic factor for survival in paired diagnosis-relapse samples of precursor B-cell acute lymphoblastic leukemia","volume":"26","author":"de Bock","year":"2012","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib124","doi-asserted-by":"crossref","first-page":"e224","DOI":"10.1038\/bcj.2014.44","article-title":"FAT1 expression and mutations in adult acute lymphoblastic leukemia","volume":"4","author":"Neumann","year":"2014","journal-title":"Blood Cancer J"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib125","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1179\/1607845413Y.0000000080","article-title":"Fat1 cadherin provides a novel minimal residual disease marker in acute lymphoblastic leukemia","volume":"18","author":"Ardjmand","year":"2013","journal-title":"Hematology"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib126","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1182\/blood-2012-11-465138","article-title":"Whole-exome sequencing in adult ETP-ALL reveals a high rate of DNMT3A mutations","volume":"121","author":"Neumann","year":"2013","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib127","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.18632\/oncotarget.2218","article-title":"Mutational spectrum of adult T-ALL","volume":"6","author":"Neumann","year":"2015","journal-title":"Oncotarget"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib128","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/ng.2538","article-title":"Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation","volume":"45","author":"Morris","year":"2013","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib129","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1182\/blood-2013-10-534271","article-title":"Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness","volume":"123","author":"Messina","year":"2014","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib130","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1172\/JCI117500","article-title":"B lymphocyte binding to E- and P-selectins is mediated through the de novo expression of carbohydrates on in vitro and in vivo activated human B cells","volume":"94","author":"Postigo","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib131","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/nm.2969","article-title":"Vascular niche E-selectin regulates hematopoietic stem cell dormancy, self renewal and chemoresistance","volume":"18","author":"Winkler","year":"2012","journal-title":"Nat Med"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib132","doi-asserted-by":"crossref","first-page":"e60823","DOI":"10.1371\/journal.pone.0060823","article-title":"Leukemia mediated endothelial cell activation modulates leukemia cell susceptibility to chemotherapy through a positive feedback loop mechanism","volume":"8","author":"Pezeshkian","year":"2013","journal-title":"PLoS One"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib133","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1158\/1078-0432.CCR-13-1037","article-title":"CD62L as a therapeutic target in chronic lymphocytic leukemia","volume":"19","author":"Burgess","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib134","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood-2013-11-538694","article-title":"Selectins and their ligands are required for homing and engraftment of BCR-ABL1+ leukemic stem cells in the bone marrow niche","volume":"123","author":"Krause","year":"2014","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib135","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/leu.2012.272","article-title":"PSGL-1\/selectin and ICAM-1\/CD18 interactions are involved in macrophage-induced drug resistance in myeloma","volume":"27","author":"Zheng","year":"2013","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib136","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2009.05.046","article-title":"CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis","volume":"138","author":"Jaiswal","year":"2009","journal-title":"Cell"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib137","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0962-8924(98)01344-0","article-title":"Integrins take partners: cross-talk between integrins and other membrane receptors","volume":"8","author":"Porter","year":"1998","journal-title":"Trends Cell Biol"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib138","doi-asserted-by":"crossref","first-page":"a002436","DOI":"10.1101\/cshperspect.a002436","article-title":"An enigmatic tail of CD28 signaling","volume":"2","author":"Boomer","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib139","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.3892\/ol.2013.1523","article-title":"Jagged1 contributes to the drug resistance of Jurkat cells in contact with human umbilical cord-derived mesenchymal stem cells","volume":"6","author":"Yuan","year":"2013","journal-title":"Oncol Lett"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib140","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1476-4598-8-35","article-title":"Identification of novel Notch target genes in T cell leukaemia","volume":"8","author":"Chadwick","year":"2009","journal-title":"Mol Cancer"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib141","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1182\/blood-2013-10-530964","article-title":"CD28-mediated pro-survival signaling induces chemotherapeutic resistance in multiple myeloma","volume":"123","author":"Murray","year":"2014","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib142","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/hep.27859","article-title":"Nuclear factor kappa B-mediated CD47 up-regulation promotes sorafenib resistance and its blockade synergizes the effect of sorafenib in hepatocellular carcinoma in mice","volume":"62","author":"Lo","year":"2015","journal-title":"Hepatology"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib143","doi-asserted-by":"crossref","first-page":"e1001796","DOI":"10.1371\/journal.pmed.1001796","article-title":"CD47 agonist peptides induce programmed cell death in refractory chronic lymphocytic leukemia B cells via PLCgamma1 activation: evidence from mice and humans","volume":"12","author":"Martinez-Torres","year":"2015","journal-title":"PLoS Med"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib144","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2141.2006.06303.x","article-title":"Chromosomal locus 19p13 as potential hotspot for aberrant gene expression in relapsed paediatric acute lymphoblastic leukaemia","volume":"135","author":"Lanciotti","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib145","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1365-2141.2005.05785.x","article-title":"The gene expression signature of relapse in paediatric acute lymphoblastic leukaemia: implications for mechanisms of therapy failure","volume":"131","author":"Beesley","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib146","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/jb\/mvv127","article-title":"Basigin (CD147), a multifunctional transmembrane glycoprotein with various binding partners","volume":"159","author":"Muramatsu","year":"2016","journal-title":"J Biochem"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib147","doi-asserted-by":"crossref","first-page":"18056","DOI":"10.1074\/jbc.M802694200","article-title":"Crystal structure of HAb18G\/CD147: implications for immunoglobulin superfamily homophilic adhesion","volume":"283","author":"Yu","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib148","first-page":"2731","article-title":"Direct contact with bone marrow stromal cells promotes the invasions of SHI-1 leukemia cells","volume":"126","author":"Li","year":"2013","journal-title":"Chin Med J (Engl)"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib149","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00277-008-0678-2","article-title":"Silencing CD147 inhibits tumor progression and increases chemosensitivity in murine lymphoid neoplasm P388D1 cells","volume":"88","author":"Jia","year":"2009","journal-title":"Ann Hematol"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib150","first-page":"2003","article-title":"CD147 silencing via RNA interference reduces tumor cell invasion, metastasis and increases chemosensitivity in pancreatic cancer cells","volume":"27","author":"Pan","year":"2012","journal-title":"Oncol Rep"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib151","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1756-9966-29-61","article-title":"RNAi-mediated silencing of CD147 inhibits tumor cell proliferation, invasion and increases chemosensitivity to cisplatin in SGC7901 cells in vitro","volume":"29","author":"Wang","year":"2010","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib152","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1182\/blood-2015-02-628560","article-title":"CD9, a key actor in the dissemination of lymphoblastic leukemia, modulating CXCR4-mediated migration via RAC1 signaling","volume":"126","author":"Arnaud","year":"2015","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib153","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bbrc.2011.04.098","article-title":"Regulation of cancer stem cell properties by CD9 in human B-acute lymphoblastic leukemia","volume":"409","author":"Yamazaki","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib154","doi-asserted-by":"crossref","first-page":"8025","DOI":"10.1158\/0008-5472.CAN-10-0996","article-title":"Cell surface tetraspanin CD9 mediates chemoresistance in small cell lung cancer","volume":"70","author":"Kohmo","year":"2010","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib155","first-page":"235","article-title":"CD44, Hyaluronan, the hematopoietic stem cell, and leukemia-initiating cells","volume":"6","author":"Zoller","year":"2015","journal-title":"Front Immunol"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib156","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/0092-8674(90)90694-A","article-title":"CD44 is the principal cell surface receptor for hyaluronate","volume":"61","author":"Aruffo","year":"1990","journal-title":"Cell"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib157","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1083\/jcb.116.3.817","article-title":"Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin","volume":"116","author":"Jalkanen","year":"1992","journal-title":"J Cell Biol"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib158","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1080\/10428190701861660","article-title":"Expression of CD44, but not CD44v6, predicts relapse in children with B cell progenitor acute lymphoblastic leukemia lacking adverse or favorable genetics","volume":"49","author":"Khan","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib159","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1182\/blood-2014-06-578856","article-title":"Genetic profile of T-cell acute lymphoblastic leukemias with MYC translocations","volume":"124","author":"La Starza","year":"2014","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib160","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/leu.2010.281","article-title":"High levels of the adhesion molecule CD44 on leukemic cells generate acute myeloid leukemia relapse after withdrawal of the initial transforming event","volume":"25","author":"Quere","year":"2011","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib161","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/sj.leu.2402336","article-title":"CD44 variant isoforms are involved in plasma cell adhesion to bone marrow stromal cells","volume":"16","author":"Van Driel","year":"2002","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib162","first-page":"299","article-title":"SDF-1 and CXCR4 in normal and malignant hematopoiesis","volume":"19","author":"Juarez","year":"2004","journal-title":"Histol Histopathol"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib163","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1007\/s00018-014-1830-x","article-title":"CXCL12\/CXCR4 axis in the pathogenesis of acute lymphoblastic leukemia (ALL): a possible therapeutic target","volume":"72","author":"de Lourdes Perim","year":"2015","journal-title":"Cell Mol Life Sci"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib164","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.ccell.2015.05.003","article-title":"CXCR4 is required for leukemia-initiating cell activity in T cell acute lymphoblastic leukemia","volume":"27","author":"Passaro","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib165","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/sj.leu.2404684","article-title":"CXCR4 antagonists mobilize childhood acute lymphoblastic leukemia cells into the peripheral blood and inhibit engraftment","volume":"21","author":"Juarez","year":"2007","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib166","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1182\/blood-2006-05-021352","article-title":"Annexin II expressed by osteoblasts and endothelial cells regulates stem cell adhesion, homing, and engraftment following transplantation","volume":"110","author":"Jung","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib167","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1182\/blood-2011-11-393348","article-title":"Annexin II interactions with the annexin II receptor enhance multiple myeloma cell adhesion and growth in the bone marrow microenvironment","volume":"119","author":"D'Souza","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib168","doi-asserted-by":"crossref","first-page":"e0140564","DOI":"10.1371\/journal.pone.0140564","article-title":"Disruption of annexin II \/p11 interaction suppresses leukemia cell binding, homing and engraftment, and sensitizes the leukemia cells to chemotherapy","volume":"10","author":"Gopalakrishnapillai","year":"2015","journal-title":"PLoS One"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib169","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/cyto.990180404","article-title":"Leukemia-associated changes identified by quantitative flow cytometry: I. CD10 expression","volume":"18","author":"Lavabre-Bertrand","year":"1994","journal-title":"Cytometry"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib170","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1172\/JCI10536","article-title":"Neutral endopeptidase inhibits prostate cancer cell migration by blocking focal adhesion kinase signaling","volume":"106","author":"Sumitomo","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib171","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/bjc.2014.289","article-title":"CD10 as a novel marker of therapeutic resistance and cancer stem cells in head and neck squamous cell carcinoma","volume":"111","author":"Fukusumi","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib172","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.biopha.2015.02.031","article-title":"CD26 a cancer stem cell marker and therapeutic target","volume":"71","author":"Davies","year":"2015","journal-title":"Biomed Pharmacother"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib173","doi-asserted-by":"crossref","first-page":"6950","DOI":"10.1158\/0008-5472.CAN-05-0647","article-title":"CD26 regulates p38 mitogen-activated protein kinase-dependent phosphorylation of integrin beta1, adhesion to extracellular matrix, and tumorigenicity of T-anaplastic large cell lymphoma Karpas 299","volume":"65","author":"Sato","year":"2005","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib174","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1182\/blood.V86.12.4617.bloodjournal86124617","article-title":"The expression of CD26 and CD40 ligand is mutually exclusive in human T-cell non-Hodgkin's lymphomas\/leukemias","volume":"86","author":"Carbone","year":"1995","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib175","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4049\/jimmunol.181.1.464","article-title":"CD73 participates in cellular multiresistance program and protects against TRAIL-induced apoptosis","volume":"181","author":"Mikhailov","year":"2008","journal-title":"J Immunol"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib176","first-page":"1","article-title":"The application of CD73 in minimal residual disease monitoring using flow cytometry in B-cell acute lymphoblastic leukemia","author":"Wang","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib177","doi-asserted-by":"crossref","first-page":"6141","DOI":"10.1182\/blood-2011-08-374728","article-title":"CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death","volume":"118","author":"Serra","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib178","doi-asserted-by":"crossref","first-page":"11378","DOI":"10.18632\/oncotarget.3409","article-title":"B-cell precursor acute lymphoblastic leukemia and stromal cells communicate through Galectin-3","volume":"6","author":"Fei","year":"2015","journal-title":"Oncotarget"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib179","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-014-0099-8","article-title":"Galectin-3 mediates bone marrow microenvironment-induced drug resistance in acute leukemia cells via Wnt\/beta-catenin signaling pathway","volume":"8","author":"Hu","year":"2015","journal-title":"J Hematol Oncol"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib180","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1038\/leu.2013.175","article-title":"Galectin-3 in pre-B acute lymphoblastic leukemia","volume":"27","author":"Fei","year":"2013","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib181","doi-asserted-by":"crossref","first-page":"17468","DOI":"10.1073\/pnas.1111138108","article-title":"Galectin-3 (Gal-3) induced by leukemia microenvironment promotes drug resistance and bone marrow lodgment in chronic myelogenous leukemia","volume":"108","author":"Yamamoto-Sugitani","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2017.06.005_bib182","doi-asserted-by":"crossref","first-page":"e37203","DOI":"10.1371\/journal.pone.0037203","article-title":"Bone marrow stromal cells modulate mouse ENT1 activity and protect leukemia cells from cytarabine induced apoptosis","volume":"7","author":"Macanas-Pirard","year":"2012","journal-title":"PLoS One"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775416301257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775416301257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T11:40:06Z","timestamp":1692877206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775416301257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":182,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0093775416301257"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2017.06.005","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eviction from the sanctuary: Development of targeted therapy against cell adhesion molecules in acute lymphoblastic leukemia","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminoncol.2017.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}